Research Article

Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre

Volume: 35 Number: 1 March 28, 2025
EN

Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre

Abstract

Objective: This study assesses the demographic and clinical characteristics, diagnostic and treatment methods, and long-term outcomes of patients diagnosed with and treated for otogenic skull base osteomyelitis (OSBO). Second, we attempted to determine the effect of hyperbaric oxygen treatment (HBOT) on the treatment of OSBO. Material and Methods: We conducted a retrospective analysis of the medical records of 17 patients hospitalised with an OSBO diagnosis in our clinic from 2017 to 2024. We reviewed the demographic infor mation, symptoms, laboratory results, imaging and treatment methods, length of hospital stay, associated complications, and follow-up periods. Results: Nearly all patients, except one, were elderly males (mean age: 68.9 years; range: 57–81 years). All patients had type 2 DM, with 88.2% (n=15) having multiple comorbidities, including hypertension and coronary artery disease. The most common symptoms were otalgia, hearing loss, and otorrhea, with cranial nerve (CN) palsy observed in 70.6% (n=12). Five patients experienced single CN involvement (CN VII in three, CN XII in one, and CN VI in one), while seven had multiple CN palsy. The mean length of hospital stay was 45 days (range: 21–80 days). In addition to intravenous antibiotic therapy, hyperbaric oxygen therapy (HBOT) was administered to 52.9% (n=9). In the HBOT group, no significant reduction was observed in morbidity or length of hospital stay. During the 7-year follow-up period, mortality occurred in 17.6% (n=3). Conclusion: OSBO should be considered as a differential diagnosis in elderly diabetic patients with persistent otalgia and otorrhea who do not respond to empirical antibiotic therapy. Although our study did not reveal any significant effects of HBOT on OSBO prognosis or length of hospital stay, randomised controlled trials are needed to assess its potential benefits.

Keywords

References

  1. Meltzer PE, Keleman G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope 1959;569:1300-16. google scholar
  2. Bernheim J, Sade J. Histopathology of the soft parts in 50 patients with malignant external otitis. J Laryngol Otol 1989;103(4):366-68. google scholar
  3. Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 2003;11(5):316-23. google scholar
  4. Chandler JR. Malignant external otitis. Laryngoscope 1968;78(8):1257-94. google scholar
  5. Rothholtz VS, Lee AD, Shamloo B, Bazargan M, Pan D, Djalilian HR. Skull base osteomyelitis: the effect of comorbid disease on hospitalization. Laryngoscope 2008;118(11):1917-24. google scholar
  6. Slattery WH 3rd, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am 1996;29(5):795-806. google scholar
  7. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988;85(3):391-8. google scholar
  8. Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004;4(1):34-9. google scholar

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Publication Date

March 28, 2025

Submission Date

December 16, 2024

Acceptance Date

January 14, 2025

Published in Issue

Year 2025 Volume: 35 Number: 1

APA
Günay, M. M., Doğan, M. F., Akyildiz, İ., Alicura Tokgöz, S., Toptaş, G., Dağlı, M., & Alay, M. T. (2025). Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre. The Turkish Journal of Ear Nose and Throat, 35(1), 1-9. https://doi.org/10.26650/Tr-ENT.2025.1602039
AMA
1.Günay MM, Doğan MF, Akyildiz İ, et al. Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre. Tr-ENT. 2025;35(1):1-9. doi:10.26650/Tr-ENT.2025.1602039
Chicago
Günay, Mehmet Murat, Mehmet Furkan Doğan, İlker Akyildiz, et al. 2025. “Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre”. The Turkish Journal of Ear Nose and Throat 35 (1): 1-9. https://doi.org/10.26650/Tr-ENT.2025.1602039.
EndNote
Günay MM, Doğan MF, Akyildiz İ, Alicura Tokgöz S, Toptaş G, Dağlı M, Alay MT (March 1, 2025) Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre. The Turkish Journal of Ear Nose and Throat 35 1 1–9.
IEEE
[1]M. M. Günay et al., “Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre”, Tr-ENT, vol. 35, no. 1, pp. 1–9, Mar. 2025, doi: 10.26650/Tr-ENT.2025.1602039.
ISNAD
Günay, Mehmet Murat - Doğan, Mehmet Furkan - Akyildiz, İlker - Alicura Tokgöz, Sibel - Toptaş, Gökhan - Dağlı, Muharrem - Alay, Mustafa Tarık. “Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre”. The Turkish Journal of Ear Nose and Throat 35/1 (March 1, 2025): 1-9. https://doi.org/10.26650/Tr-ENT.2025.1602039.
JAMA
1.Günay MM, Doğan MF, Akyildiz İ, Alicura Tokgöz S, Toptaş G, Dağlı M, Alay MT. Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre. Tr-ENT. 2025;35:1–9.
MLA
Günay, Mehmet Murat, et al. “Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre”. The Turkish Journal of Ear Nose and Throat, vol. 35, no. 1, Mar. 2025, pp. 1-9, doi:10.26650/Tr-ENT.2025.1602039.
Vancouver
1.Mehmet Murat Günay, Mehmet Furkan Doğan, İlker Akyildiz, Sibel Alicura Tokgöz, Gökhan Toptaş, Muharrem Dağlı, Mustafa Tarık Alay. Otogenic Skull Base Osteomyelitis: Clinical Presentation, Diagnostic and Therapeutic Challenges, and Long-Term Outcomes from a Single Tertiary Centre. Tr-ENT. 2025 Mar. 1;35(1):1-9. doi:10.26650/Tr-ENT.2025.1602039